Personal tools

Coexpression cluster:C151: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C151_CD14_Natural_Basophils_CD8_Eosinophils_CD4_Mast |id=C151 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C151_CD14_Natural_Basophils_CD8_Eosinophils_CD4_Mast
|full_id=C151_CD14_Natural_Basophils_CD8_Eosinophils_CD4_Mast
|gostat_on_coexpression_clusters=GO:0030229!very-low-density lipoprotein receptor activity!0.0155274932297186!3949$GO:0004883!glucocorticoid receptor activity!0.0155274932297186!2908$GO:0065007!biological regulation!0.0214504329188226!7159;3949;2908;1316;29110$GO:0045192!low-density lipoprotein catabolic process!0.0228181386588504!3949$GO:0004871!signal transducer activity!0.0228181386588504!7159;3949;2908;29110$GO:0060089!molecular transducer activity!0.0228181386588504!7159;3949;2908;29110$GO:0042159!lipoprotein catabolic process!0.0266107250734418!3949$GO:0030299!cholesterol absorption!0.0275930581833342!3949$GO:0044241!lipid digestion!0.0275930581833342!3949$GO:0050892!intestinal absorption!0.0284503157301035!3949$GO:0005041!low-density lipoprotein receptor activity!0.0284503157301035!3949$GO:0030228!lipoprotein receptor activity!0.0284503157301035!3949$GO:0042632!cholesterol homeostasis!0.0286397731579021!3949$GO:0055092!sterol homeostasis!0.0286397731579021!3949$GO:0030169!low-density lipoprotein binding!0.0286397731579021!3949$GO:0055088!lipid homeostasis!0.0286397731579021!3949$GO:0015918!sterol transport!0.0286397731579021!3949$GO:0051059!NF-kappaB binding!0.0286397731579021!7159$GO:0030301!cholesterol transport!0.0286397731579021!3949$GO:0022600!digestive system process!0.0286397731579021!3949$GO:0006952!defense response!0.0286397731579021!2908;29110$GO:0007530!sex determination!0.0296085113281691!2908$GO:0050794!regulation of cellular process!0.0315335977428127!7159;2908;1316;29110$GO:0030183!B cell differentiation!0.0356404869340457!1316$GO:0008034!lipoprotein binding!0.0356404869340457!3949$GO:0006493!protein amino acid O-linked glycosylation!0.0356404869340457!3949$GO:0050789!regulation of biological process!0.0356404869340457!7159;2908;1316;29110$GO:0005905!coated pit!0.0475738017393153!3949
|id=C151
|id=C151
}}
}}

Revision as of 17:35, 18 May 2012


Full id: C151_CD14_Natural_Basophils_CD8_Eosinophils_CD4_Mast



Phase1 CAGE Peaks

Hg19::chr10:17553392..17553414,-p@chr10:17553392..17553414
-
Hg19::chr10:17553468..17553477,-p@chr10:17553468..17553477
-
Hg19::chr10:3799978..3799981,+p@chr10:3799978..3799981
+
Hg19::chr10:3825575..3825583,-p@chr10:3825575..3825583
-
Hg19::chr10:3825586..3825604,+p@chr10:3825586..3825604
+
Hg19::chr10:3825673..3825701,+p@chr10:3825673..3825701
+
Hg19::chr10:3827371..3827386,-p2@KLF6
Hg19::chr10:3847590..3847615,+p@chr10:3847590..3847615
+
Hg19::chr10:3847617..3847639,+p@chr10:3847617..3847639
+
Hg19::chr10:3894565..3894585,-p@chr10:3894565..3894585
-
Hg19::chr10:3894940..3894969,+p@chr10:3894940..3894969
+
Hg19::chr10:3930116..3930153,-p@chr10:3930116..3930153
-
Hg19::chr10:3930230..3930262,+p@chr10:3930230..3930262
+
Hg19::chr10:99408822..99408843,-p@chr10:99408822..99408843
-
Hg19::chr11:108338193..108338213,-p2@C11orf65
Hg19::chr11:58341454..58341467,+p@chr11:58341454..58341467
+
Hg19::chr11:9482158..9482185,-p1@LOC644656
Hg19::chr12:47785018..47785030,+p@chr12:47785018..47785030
+
Hg19::chr12:62997510..62997571,-p1@C12orf61
Hg19::chr12:64616313..64616329,-p2@C12orf66
Hg19::chr12:64845781..64845792,+p5@TBK1
Hg19::chr12:92270910..92270924,-p@chr12:92270910..92270924
-
Hg19::chr12:96793507..96793519,+p@chr12:96793507..96793519
+
Hg19::chr13:114894670..114894687,+p@chr13:114894670..114894687
+
Hg19::chr13:52378012..52378023,+p5@ENST00000456688
Hg19::chr13:52378405..52378429,+p3@ENST00000456688
Hg19::chr13:71865578..71865595,+p@chr13:71865578..71865595
+
Hg19::chr13:99935844..99935865,-p@chr13:99935844..99935865
-
Hg19::chr14:102414353..102414415,-p@chr14:102414353..102414415
-
Hg19::chr14:23790136..23790163,-p@chr14:23790136..23790163
-
Hg19::chr14:81636804..81636835,+p@chr14:81636804..81636835
+
Hg19::chr14:81685834..81685853,+p@chr14:81685834..81685853
+
Hg19::chr15:85525866..85525879,-p@chr15:85525866..85525879
-
Hg19::chr16:20912122..20912137,-p3@DCUN1D3
Hg19::chr17:26926162..26926194,+p1@SPAG5-AS1
Hg19::chr17:33569446..33569460,+p@chr17:33569446..33569460
+
Hg19::chr17:33570565..33570588,-p@chr17:33570565..33570588
-
Hg19::chr17:38255699..38255715,+p@chr17:38255699..38255715
+
Hg19::chr17:38476516..38476528,-p@chr17:38476516..38476528
-
Hg19::chr17:38477491..38477543,-p@chr17:38477491..38477543
-
Hg19::chr18:11851262..11851282,-p@chr18:11851262..11851282
-
Hg19::chr18:3448924..3448950,-p@chr18:3448924..3448950
-
Hg19::chr18:60829037..60829058,-p@chr18:60829037..60829058
-
Hg19::chr18:711915..711927,+p@chr18:711915..711927
+
Hg19::chr19:11201287..11201316,+p9@LDLR
Hg19::chr19:14480830..14480845,+p@chr19:14480830..14480845
+
Hg19::chr19:2504035..2504041,+p@chr19:2504035..2504041
+
Hg19::chr19:45959099..45959131,-p@chr19:45959099..45959131
-
Hg19::chr1:171455486..171455504,+p@chr1:171455486..171455504
+
Hg19::chr1:184942941..184942967,-p@chr1:184942941..184942967
-
Hg19::chr1:206753511..206753542,+p@chr1:206753511..206753542
+
Hg19::chr1:221885672..221885702,-p@chr1:221885672..221885702
-
Hg19::chr1:221915746..221915770,+p@chr1:221915746..221915770
+
Hg19::chr1:221916350..221916370,+p@chr1:221916350..221916370
+
Hg19::chr1:221916408..221916416,+p@chr1:221916408..221916416
+
Hg19::chr1:224033536..224033567,-p4@TP53BP2
Hg19::chr1:226867811..226867833,-p@chr1:226867811..226867833
-
Hg19::chr1:226891331..226891354,+p@chr1:226891331..226891354
+
Hg19::chr1:226891361..226891380,+p@chr1:226891361..226891380
+
Hg19::chr1:234746616..234746632,-p@chr1:234746616..234746632
-
Hg19::chr1:24286129..24286138,-p@chr1:24286129..24286138
-
Hg19::chr1:37944377..37944382,-p@chr1:37944377..37944382
-
Hg19::chr1:59249927..59249963,+p@chr1:59249927..59249963
+
Hg19::chr22:36782241..36782263,+p@chr22:36782241..36782263
+
Hg19::chr22:42929620..42929624,+p@chr22:42929620..42929624
+
Hg19::chr2:135810133..135810145,-p@chr2:135810133..135810145
-
Hg19::chr2:178077129..178077179,-p@chr2:178077129..178077179
-
Hg19::chr2:178129611..178129638,+p@chr2:178129611..178129638
+
Hg19::chr2:178129685..178129703,+p@chr2:178129685..178129703
+
Hg19::chr2:191979419..191979439,+p@chr2:191979419..191979439
+
Hg19::chr2:192015854..192015875,+p@chr2:192015854..192015875
+
Hg19::chr2:232258341..232258363,-p@chr2:232258341..232258363
-
Hg19::chr2:241564662..241564674,-p@chr2:241564662..241564674
-
Hg19::chr2:48133949..48133962,+p2@ENST00000417692
Hg19::chr2:61991361..61991380,-p@chr2:61991361..61991380
-
Hg19::chr2:61991387..61991406,-p@chr2:61991387..61991406
-
Hg19::chr2:70370094..70370116,+p@chr2:70370094..70370116
+
Hg19::chr2:88927395..88927420,+p2@uc002std.1
Hg19::chr2:88927653..88927687,-p@chr2:88927653..88927687
-
Hg19::chr3:11331017..11331048,+p@chr3:11331017..11331048
+
Hg19::chr3:113933266..113933281,+p2@ENST00000493033
p2@uc003ebe.1
Hg19::chr3:5026037..5026052,+p@chr3:5026037..5026052
+
Hg19::chr3:5048654..5048681,+p@chr3:5048654..5048681
+
Hg19::chr4:103436594..103436605,+p@chr4:103436594..103436605
+
Hg19::chr4:139936151..139936155,-p@chr4:139936151..139936155
-
Hg19::chr4:139938135..139938140,+p@chr4:139938135..139938140
+
Hg19::chr4:170541477..170541493,-p@chr4:170541477..170541493
-
Hg19::chr4:2748210..2748233,+p@chr4:2748210..2748233
+
Hg19::chr5:142784911..142784925,-p15@NR3C1
Hg19::chr5:1521157..1521164,+p@chr5:1521157..1521164
+
Hg19::chr5:75843262..75843275,-p@chr5:75843262..75843275
-
Hg19::chr6:138028841..138028852,-p@chr6:138028841..138028852
-
Hg19::chr6:28105422..28105451,-p1@uc003nkl.1
p1@uc010jqw.1
p2@uc003nkk.1
Hg19::chr6:29617855..29617871,-p@chr6:29617855..29617871
-
Hg19::chr6:33281942..33281963,+p@chr6:33281942..33281963
+
Hg19::chr6:33386279..33386304,+p@chr6:33386279..33386304
+
Hg19::chr7:12727041..12727066,-p@chr7:12727041..12727066
-
Hg19::chr7:130626444..130626463,+p@chr7:130626444..130626463
+
Hg19::chr7:151722642..151722676,-p@chr7:151722642..151722676
-
Hg19::chr7:30634289..30634301,-p@chr7:30634289..30634301
-
Hg19::chr7:44673697..44673718,+p@chr7:44673697..44673718
+
Hg19::chr7:44925415..44925438,+p@chr7:44925415..44925438
+
Hg19::chr7:66093620..66093638,-p@chr7:66093620..66093638
-
Hg19::chr8:101964395..101964441,+p@chr8:101964395..101964441
+
Hg19::chr8:141475127..141475140,+p@chr8:141475127..141475140
+
Hg19::chr8:141601516..141601544,-p@chr8:141601516..141601544
-
Hg19::chr9:132891288..132891326,-p@chr9:132891288..132891326
-
Hg19::chr9:135991340..135991361,+p@chr9:135991340..135991361
+
Hg19::chr9:26892877..26892898,+p@chr9:26892877..26892898
+
Hg19::chr9:34989341..34989353,-p@chr9:34989341..34989353
-
Hg19::chr9:91933623..91933645,-p@chr9:91933623..91933645
-
Hg19::chr9:99417081..99417092,+p@chr9:99417081..99417092
+
Hg19::chrX:70752106..70752119,+p@chrX:70752106..70752119
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0030229very-low-density lipoprotein receptor activity0.0155274932297186
GO:0004883glucocorticoid receptor activity0.0155274932297186
GO:0065007biological regulation0.0214504329188226
GO:0045192low-density lipoprotein catabolic process0.0228181386588504
GO:0004871signal transducer activity0.0228181386588504
GO:0060089molecular transducer activity0.0228181386588504
GO:0042159lipoprotein catabolic process0.0266107250734418
GO:0030299cholesterol absorption0.0275930581833342
GO:0044241lipid digestion0.0275930581833342
GO:0050892intestinal absorption0.0284503157301035
GO:0005041low-density lipoprotein receptor activity0.0284503157301035
GO:0030228lipoprotein receptor activity0.0284503157301035
GO:0042632cholesterol homeostasis0.0286397731579021
GO:0055092sterol homeostasis0.0286397731579021
GO:0030169low-density lipoprotein binding0.0286397731579021
GO:0055088lipid homeostasis0.0286397731579021
GO:0015918sterol transport0.0286397731579021
GO:0051059NF-kappaB binding0.0286397731579021
GO:0030301cholesterol transport0.0286397731579021
GO:0022600digestive system process0.0286397731579021
GO:0006952defense response0.0286397731579021
GO:0007530sex determination0.0296085113281691
GO:0050794regulation of cellular process0.0315335977428127
GO:0030183B cell differentiation0.0356404869340457
GO:0008034lipoprotein binding0.0356404869340457
GO:0006493protein amino acid O-linked glycosylation0.0356404869340457
GO:0050789regulation of biological process0.0356404869340457
GO:0005905coated pit0.0475738017393153



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C151&oldid=1702484"